Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable cyclin-dependent protein serine/threonine kinase regulator activity and identical protein binding activity. Predicted to contribute to ubiquitin protein ligase activity. Predicted to be involved in several processes, including G0 to G1 transition; negative regulation of Notch signaling pathway; and negative regulation of triglyceride metabolic process. Part of mediator complex. Is expressed in central nervous system; limb; retina; and tongue. Orthologous to human CCNC (cyclin C).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.